LAB FY 2017 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

FY 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$102M-2.4% YoY

Gross Profit

$52M51.0% margin

Operating Income

-$58M-57.3% margin

Net Income

-$61M-59.4% margin

EPS (Diluted)

$-1.84

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$26M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$287M

Total Liabilities

$256M

Stockholders' Equity

$31M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$102M	$104M	-2.4%
Gross Profit	$52M	$58M	-11.0%
Operating Income	-$58M	-$73M	+20.3%
Net Income	-$61M	-$76M	+20.3%